Show simple item record

dc.contributor.authorWard, W.E.
dc.contributor.authorAshaye, K.
dc.date.accessioned2011-04-21T07:36:41Z
dc.date.available2011-04-21T07:36:41Z
dc.date.issued2008
dc.identifier.citationWard , W E & Ashaye , K 2008 , ' An observational study of the needs and quality of life amongst patients in the treatment of Alzheimer's Dementia with cholinesterase inhibitors ' , Current Aging Science , vol. 1 , no. 2 , pp. 140-143 .
dc.identifier.issn1874-6098
dc.identifier.otherPURE: 129873
dc.identifier.otherPURE UUID: c30dffe3-6902-4832-9115-f44bb799442a
dc.identifier.otherdspace: 2299/5710
dc.identifier.urihttp://hdl.handle.net/2299/5710
dc.descriptionOriginal article can be found at : http://www.benthamscience.com/ Copyright Bentham Science Publishers Ltd. [Full text of this article is not available in the UHRA]
dc.description.abstractAlzheimer’s dementia is one of the most commost mental health disorders associated with aging. In its earlier stages sufferers live independently but gradually rely increasingly on loved ones or formal carers for support as the illness progresses. Its treatment involves both medical and social care. This study assesses the impact of outpatients’ care and cholinesterase inhibitors in patients being treated for Alzheimer’s dementia. The needs and quality of life of patients attending an outpatients dementia care service were assessed using the Camberwell Assessment of Need for the Elderly (CANE) and Quality of Life in Alzheimer’s Disease: Patient and Caregiver report. Other tools used were the Problems Checklist and Carer Strain, the Minimental State Examination (MMSE) and a proforma to obtain sociodemographic details. All patients who had informal care were assessed using the questionnaires. 104 patients were seen of whom 34 were new and 70 were follow-up patients. 43 patients lived alone while the rest lived with their spouses or other relatives such as children. There was reduction in the number of CANE unmet needs and increased combined Quality of Life in Alzheimer’s Dementia scores in the first three months amongst the newly referred patients. The findings suggest that outpatients’ dementia care and prescribing of cholinesterase inhibitors helped to meet the needs of patients and improve patients’ quality of life in first three months.en
dc.language.isoeng
dc.relation.ispartofCurrent Aging Science
dc.titleAn observational study of the needs and quality of life amongst patients in the treatment of Alzheimer's Dementia with cholinesterase inhibitorsen
dc.contributor.institutionCentre for Postgraduate Medicine
dc.description.statusPeer reviewed
dcterms.dateAccepted2008
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record